epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Alyacen 1/ 35
    norethindrone/ ethinyl estradiol
  • remove Demadex
    torsemide
  • remove Lutera
    levonorgestrel/ ethinyl estradiol
  • remove Metanx
    levomefolate/ Schizochytrium/ pyridoxal phosphate/ methylcobalamin

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Alyacen 1/35 (norethindrone/ ethinyl estradiol) + Lutera (levonorgestrel/ ethinyl estradiol)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive)

avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

norethindrone (contraceptive) + levonorgestrel (contraceptive)

avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

Smiley face Smiley face Alyacen 1/35 (norethindrone/ ethinyl estradiol) + Demadex (torsemide)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + torsemide

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Demadex (torsemide) + Lutera (levonorgestrel/ ethinyl estradiol)

Monitor/Modify Tx


torsemide + ethinyl estradiol (contraceptive)

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information